Glycodendrimers: versatile tools for nanotechnology

Combining nanotechnology with glycobiology has triggered an exponential growth of research activities in the design of novel functional bionanomaterials (glyconanotechnology). More specifically, recent synthetic advances towards the tailored and versatile design of glycosylated nanoparticles namely glyconanoparticles, considered as synthetic mimetics of natural glycoconjugates, paved the way toward diverse biomedical applications. The accessibility of a wide variety of these structured nanosystems, in terms of shapes, sizes, and organized around stable nanoparticles have readily contributed to their development and applications in nanomedicine. In this context, glycosylated gold-nanoparticles (GNPs), glycosylated quantum dots (QDs), fullerenes, single-wall natotubes (SWNTs), and self-assembled glycononanoparticles using amphiphilic glycopolymers or glycodendrimers have received considerable attention to afford powerful imaging, therapeutic, and biodiagnostic devices. This review will provide an overview of the most recent syntheses and applications of glycodendrimers in glycoscience that have permitted to deepen our understanding of multivalent carbohydrate-protein interactions. Together with synthetic breast cancer vaccines, inhibitors of bacterial adhesions to host tissues including sensitive detection devices, these novel bionanomaterials are finding extensive relevance.

[1]  L. BenMohamed,et al.  Towards a Self‐Adjuvanting Multivalent B and T cell Epitope Containing Synthetic Glycolipopeptide Cancer Vaccine , 2008, ChemMedChem.

[2]  I. García,et al.  Glyconanoparticles: New Nanomaterials for Biological Applications , 2010 .

[3]  J. Kovensky,et al.  Clustering of Escherichia coli type-1 fimbrial adhesins by using multimeric heptyl α-D-mannoside probes with a carbohydrate core. , 2011, Chemistry.

[4]  R. Roy,et al.  Synthesis and antibody binding properties of glycodendrimers bearing the tumor related T-antigen , 2001 .

[5]  S. Morey,et al.  Development and Characterization of Monoclonal Antibody to T-Antigen: (Galβl—3GalNAc-α-O) , 1998 .

[6]  R. Pieters,et al.  Tuning the preference of thiodigalactoside- and lactosamine-based ligands to galectin-3 over galectin-1. , 2013, Journal of medicinal chemistry.

[7]  S. Morey,et al.  Development and characterization of monoclonal antibody to T-antigen: (gal beta1-3GalNAc-alpha-O). , 1998, Hybridoma.

[8]  R. Roy,et al.  Design and Creativity in Synthesis of Multivalent Neoglycoconjugates , 2010, Advances in Carbohydrate Chemistry and Biochemistry.

[9]  M. Marradi,et al.  Glyconanoparticles polyvalent tools to study carbohydrate-based interactions. , 2010, Advances in carbohydrate chemistry and biochemistry.

[10]  K A Baggerly,et al.  New tumor markers: CA125 and beyond , 2005, International Journal of Gynecologic Cancer.

[11]  D. Kasper,et al.  Coming of age: carbohydrates and immunity , 2005, European journal of immunology.

[12]  R. D. De Silva,et al.  Immunological response from an entirely carbohydrate antigen: design of synthetic vaccines based on Tn-PS A1 conjugates. , 2009, Journal of the American Chemical Society.

[13]  R. Roy,et al.  Application of Multivalent Mannosylated Dendrimers in Glycobiology , 2007, Comprehensive Glycoscience.

[14]  J. Rojo,et al.  Gold Glyconanoparticles as Water-Soluble Polyvalent Models To Study Carbohydrate Interactions. , 2001, Angewandte Chemie.

[15]  L. Morelli,et al.  Carbohydrates and Immunology: Synthetic Oligosaccharide Antigens for Vaccine Formulation , 2011 .

[16]  Kheireddine El-Boubbou,et al.  Glyco-nanomaterials: translating insights from the "sugar-code" to biomedical applications. , 2011, Current medicinal chemistry.

[17]  G. Springer T and Tn, general carcinoma autoantigens. , 1984, Science.

[18]  Alssandra Franco Glycoconjugates as vaccines for cancer immunotherapy: clinical trials and future directions. , 2008, Anti-Cancer Agents in Medicinal Chemistry.

[19]  A. Almogren,et al.  Anti-Thomsen-Friedenreich-Ag (anti-TF-Ag) potential for cancer therapy. , 2012, Frontiers in bioscience.

[20]  M. Mutter,et al.  A convenient synthesis of cyclic peptides as regioselectively addressable functionalized templates (RAFT) , 1995 .

[21]  R. Roy,et al.  Expeditive synthesis of glycodendrimer scaffolds based on versatile TRIS and mannoside derivatives. , 2008, The Journal of organic chemistry.

[22]  U. Nilsson,et al.  Inhibition of galectins with small molecules. , 2011, Chimia.

[23]  O. Finn,et al.  Cancer vaccines: between the idea and the reality , 2003, Nature Reviews Immunology.

[24]  R. Roy,et al.  Glycodendrimers as anti-adhesion drugs against type 1 fimbriated E. coli uropathogenic infections. , 2007, Mini reviews in medicinal chemistry.

[25]  A. Imberty,et al.  Glycomimetics and glycodendrimers as high affinity microbial anti-adhesins. , 2008, Chemistry.

[26]  L. BenMohamed,et al.  Antitumor activity of a self-adjuvanting glyco-lipopeptide vaccine bearing B cell, CD4+ and CD8+ T cell epitopes , 2009, Cancer Immunology, Immunotherapy.

[27]  Chang‐Ming Dong Glyconanoparticles for biomedical applications. , 2011, Combinatorial chemistry & high throughput screening.

[28]  S. Danishefsky,et al.  From the Laboratory to the Clinic: A Retrospective on Fully Synthetic Carbohydrate-Based Anticancer Vaccines , 2000 .

[29]  R. Roy,et al.  First synthesis of "Majoral-Type" glycodendrimers bearing covalently bound alpha-D-mannopyranoside residues onto a hexachlocyclotriphosphazene core. , 2008, The Journal of organic chemistry.

[30]  G. Ragupathi Carbohydrate antigens as targets for active specific immunotherapy , 1996, Cancer Immunology, Immunotherapy.

[31]  J. Barchi,et al.  Varied presentation of the Thomsen-Friedenreich disaccharide tumor-associated carbohydrate antigen on gold nanoparticles. , 2008, Carbohydrate research.

[32]  F. Avci,et al.  How bacterial carbohydrates influence the adaptive immune system. , 2010, Annual review of immunology.

[33]  J. M. de la Fuente,et al.  Glyconanoparticles: types, synthesis and applications in glycoscience, biomedicine and material science. , 2006, Biochimica et biophysica acta.

[34]  H. Gabius,et al.  Lactose-containing starburst dendrimers: influence of dendrimer generation and binding-site orientation of receptors (plant/animal lectins and immunoglobulins) on binding properties. , 1999, Glycobiology.

[35]  R. Roy,et al.  Simultaneous binding of mouse monoclonal antibody and streptavidin to heterobifunctional dendritic L-lysine core bearing T-antigen tumor marker and biotin. , 2001, Bioorganic & medicinal chemistry.

[36]  M. Baek,et al.  Design and synthesis of water-soluble glycopolymers bearing breast tumor marker and enhanced lipophilicity for solid-phase assays. , 2000, Biomacromolecules.

[37]  J. Barchi,et al.  Design and synthesis of multifunctional gold nanoparticles bearing tumor-associated glycopeptide antigens as potential cancer vaccines. , 2012, Bioconjugate chemistry.

[38]  R. Roy,et al.  Recent trends in glycodendrimer syntheses and applications. , 2008, Current topics in medicinal chemistry.

[39]  T. Lindhorst,et al.  The Bacterial Lectin FimH, a Target for Drug Discovery – Carbohydrate Inhibitors of Type 1 Fimbriae‐Mediated Bacterial Adhesion , 2011 .

[40]  R. Roy,et al.  Synthesis and protein binding properties of T-antigen containing GlycoPAMAM dendrimers. , 2002, Bioorganic & medicinal chemistry.

[41]  H. Gabius The sugar code : fundamentals of glycosciences , 2009 .

[42]  R. Roy,et al.  Dendrimer‐Coated Carbohydrate Residues as Drug Delivery Trojan Horses in Glycoscience , 2012 .

[43]  J. Kovensky,et al.  Synthetic Multimeric Heptyl Mannosides as Potent Antiadhesives of Uropathogenic Escherichia coli , 2009, ChemMedChem.

[44]  V. Huxley,et al.  Inhibition of spontaneous breast cancer metastasis by anti-Thomsen-Friedenreich antigen monoclonal antibody JAA-F11. , 2006, Neoplasia.

[45]  H. Gabius,et al.  Inhibitory potential of chemical substitutions at bioinspired sites of β-D-galactopyranose on neoglycoprotein/cell surface binding of two classes of medically relevant lectins. , 2011, Bioorganic & medicinal chemistry.

[46]  R. Roy,et al.  Synthesis of N,N′-Bis(acrylamido)acetic Acid-Based T-Antigen Glycodendrimers and Their Mouse Monoclonal IgG Antibody Binding Properties. , 2001 .

[47]  S. Hakomori,et al.  Tumor-associated carbohydrate antigens. , 1984, Annual review of immunology.

[48]  H. Gabius,et al.  Synthesis and screening of a small glycomimetic library for inhibitory activity on medically relevant galactoside-specific lectins in assays of increasing biorelevance , 2010 .

[49]  R. Roy A Decade of Glycodendrimer Chemistry , 2003 .

[50]  Angela Liakatos,et al.  Synthetic glycopeptides for the development of cancer vaccines. , 2007, Current opinion in molecular therapeutics (Print).

[51]  A. Imberty,et al.  Synthesis and Biological Applications of Glycoconjugates , 2012 .

[52]  Philip S. Livingston,et al.  Approaches to Augmenting the Immunogenicity of Melanoma Gangliosides: From Whole Melanoma Cells to Ganglioside‐KLH Conjugate Vaccines , 1995, Immunological reviews.

[53]  R. Roy,et al.  Organic chemistry and immunochemical strategies in the design of potent carbohydrate-based vaccines. , 2011, Chimia.

[54]  S. Svarovsky,et al.  Synthesis of gold nanoparticles bearing the Thomsen–Friedenreich disaccharide: a new multivalent presentation of an important tumor antigen , 2005 .

[55]  R. Roy,et al.  Applications of Glyconanoparticles as "Sweet" Glycobiological Therapeutics and Diagnostics , 2013 .

[56]  R. Roy,et al.  Glycodendrimers: novel glycotope isosteres unmasking sugar coding. case study with T-antigen markers from breast cancer MUC1 glycoprotein. , 2002, Journal of biotechnology.

[57]  G. Ragupathi,et al.  Carbohydrate vaccines that induce antibodies against cancer. 2. Previous experience and future plans , 1997, Cancer Immunology, Immunotherapy.

[58]  G. Jung,et al.  Synthetic lipopeptide adjuvants and Toll-like receptor 2--structure-activity relationships. , 2004, Vaccine.

[59]  A. Nesburn,et al.  Linear and Branched Glyco-Lipopeptide Vaccines Follow Distinct Cross-Presentation Pathways and Generate Different Magnitudes of Antitumor Immunity , 2010, PloS one.

[60]  J. Fahy,et al.  Hexaphenylbenzene as a rigid template for the straightforward syntheses of "star-shaped" glycodendrimers. , 2011, The Journal of organic chemistry.

[61]  Clemens Burda,et al.  The unique role of nanoparticles in nanomedicine : imaging , drug delivery and therapy , 2012 .

[62]  L. Cipolla,et al.  Glycoconjugates in cancer therapy. , 2008, Anti-cancer agents in medicinal chemistry.

[63]  M. Tremblay,et al.  Galectin-1-Specific Inhibitors as a New Class of Compounds To Treat HIV-1 Infection , 2011, Antimicrobial Agents and Chemotherapy.

[64]  Sachiko Sato,et al.  Synthesis of stable and selective inhibitors of human galectins-1 and -3. , 2008, Bioorganic & medicinal chemistry.

[65]  K. Pienta,et al.  Inhibition of prostate cancer bone metastasis by synthetic TF antigen mimic/galectin-3 inhibitor lactulose-L-leucine. , 2012, Neoplasia.

[66]  Allen,et al.  From the Laboratory to the Clinic: A Retrospective on Fully Synthetic Carbohydrate-Based Anticancer Vaccines Frequently used abbreviations are listed in the appendix. , 2000, Angewandte Chemie.

[67]  R. Roy Carbohydrate-based vaccines , 2008 .

[68]  S. Nishimura,et al.  Inhibition of Adhesion of Type 1 Fimbriated Escherichia coli to Highly Mannosylated Ligands , 2002, Chembiochem : a European journal of chemical biology.

[69]  G. Boons,et al.  Carbohydrate-based vaccines and immunotherapies , 2009 .

[70]  O. Renaudet,et al.  Synthesis of multi-antigenic platforms as vaccine candidates against cancers , 2013 .

[71]  H. Kunz,et al.  Synthetic vaccines from tumor-associated glycopeptide antigens. , 2011, Chimia.

[72]  S. Hintermann,et al.  Toward optimized carbohydrate-based anticancer vaccines: Epitope clustering, carrier structure, and adjuvant all influence antibody responses to Lewisy conjugates in mice , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[73]  R. Narain,et al.  Engineered carbohydrate-based materials for biomedical applications : , 2011 .

[74]  H. Ananthaswamy,et al.  Inhibition of colony formation in agarose of metastatic human breast carcinoma and melanoma cells by synthetic glycoamine analogs , 1996, Clinical & Experimental Metastasis.

[75]  Hayyoung Lee,et al.  The structural basis of lipopolysaccharide recognition by the TLR4–MD-2 complex , 2009, Nature.

[76]  I. García,et al.  Glyconanoparticles as Multifunctional and Multimodal Carbohydrate Systems , 2013 .

[77]  C. Leclerc,et al.  Carbohydrate antigens: synthesis aspects and immunological applications in cancer. , 2006, Mini reviews in medicinal chemistry.

[78]  S. Paik,et al.  Recognition of lipopeptide patterns by Toll-like receptor 2-Toll-like receptor 6 heterodimer. , 2009, Immunity.

[79]  R. Roy,et al.  A first QSAR model for galectin-3 glycomimetic inhibitors based on 3D docked structures. , 2006, Medicinal chemistry.

[80]  A. Imberty,et al.  Glycoliposomes and metallic glyconanoparticles in glycoscience , 2012 .

[81]  Mathias Brust,et al.  Synthesis of thiol-derivatised gold nanoparticles in a two-phase liquid-liquid system , 1994 .

[82]  R. Roy,et al.  Diazo transfer and click chemistry in the solid phase syntheses of lysine-based glycodendrimers as antagonists against Escherichia coli FimH. , 2012, Molecular pharmaceutics.

[83]  A. Imberty,et al.  Multivalent glycoconjugates as anti-pathogenic agents. , 2013, Chemical Society reviews.

[84]  V. Křen,et al.  Dendri-RAFTs: a second generation of cyclopeptide-based glycoclusters. , 2011, Organic & biomolecular chemistry.

[85]  R. Roy,et al.  Glycodendrimers as functional antigens and antitumor vaccines , 2012 .

[86]  I. García,et al.  Glyconanoparticles: multifunctional nanomaterials for biomedical applications. , 2010, Nanomedicine.

[87]  Mingdi Yan,et al.  Glyconanomaterials: Synthesis, Characterization, and Ligand Presentation , 2010, Advanced materials.

[88]  R. Roy,et al.  Glycodendrimer coated gold nanoparticles for proteins detection based on surface energy transfer process , 2012 .

[89]  R. Roy,et al.  Multivalent glycoconjugate syntheses and applications using aromatic scaffolds. , 2013, Chemical Society reviews.

[90]  K. Lloyd,et al.  Carbohydrate vaccines that induce antibodies against cancer. 1. Rationale , 1997, Cancer Immunology, Immunotherapy.

[91]  Sachiko Sato,et al.  Aryl O- and S-galactosides and lactosides as specific inhibitors of human galectins-1 and -3: role of electrostatic potential at O-3. , 2006, Bioorganic & medicinal chemistry letters.

[92]  J. Bouckaert,et al.  The functional valency of dodecamannosylated fullerenes with Escherichia coli FimH--towards novel bacterial antiadhesives. , 2011, Chemical communications.

[93]  E. Schmitt,et al.  Fully synthetic vaccines consisting of tumor-associated MUC1 glycopeptides and a lipopeptide ligand of the Toll-like receptor 2. , 2010, Angewandte Chemie.

[94]  R. P. Cheng,et al.  Development, characterization, and immunotherapeutic use of peptide mimics of the Thomsen-Friedenreich carbohydrate antigen. , 2009, Neoplasia.

[95]  M. Carmen Galan,et al.  Carbohydrate Chemistry in Drug Discovery , 2011 .

[96]  Zhongwu Guo,et al.  Recent development in carbohydrate-based cancer vaccines. , 2009, Current opinion in chemical biology.

[97]  R. Roy New trends in carbohydrate-based vaccines. , 2004, Drug discovery today. Technologies.

[98]  Yiyun Cheng,et al.  Dendrimer-based drug delivery systems : from theory to practice , 2012 .

[99]  S. Gendler,et al.  Structure and function of the cell surface (tethered) mucins. , 2008, Annual review of physiology.

[100]  S. Hakomori,et al.  Synthetic vaccines : synthesis of a dimeric Tn antigen-lipopeptide conjugate that elicits immune responses against Tn-expressing glycoproteins , 1994 .

[101]  T. Toyokuni,et al.  Synthetic carbohydrate vaccines based on tumour-associated antigens , 1996 .

[102]  H. Kunz,et al.  Synthetic glycopeptides from the mucin family as potential tools in cancer immunotherapy. , 2006, Current cancer drug targets.

[103]  R. Roy,et al.  Carbohydrate-coated lanthanide-doped upconverting nanoparticles for lectin recognition , 2010 .

[104]  R. Narain Engineered carbohydrate-based materials for biomedical applications : polymers, surfaces, dendrimers, nanoparticles, and hydrogels , 2011 .

[105]  I. García,et al.  Carbohydrate-based nanoparticles for potential applications in medicine. , 2011, Progress in molecular biology and translational science.